Literature DB >> 17430235

Adiposity and Alzheimer's disease.

Jose A Luchsinger1, Richard Mayeux.   

Abstract

The objective of this manuscript is to provide a comprehensive review of the relation between adiposity and Alzheimer's disease (AD), its potential mechanisms, and issues in its study. Adiposity represents the body fat tissue content. When the degree of adiposity increases it can be defined as being overweight or obese by measures such as the body mass index. Being overweight or obese is a cause of hyperinsulinemia and diabetes, both of which are risk factors for AD. However, the epidemiologic evidence linking the degree of adiposity and AD is conflicting. Traditional adiposity measures such as body mass index have decreased validity in the elderly. Increased adiposity in early or middle adult life leads to hyperinsulinemia which may lead to diabetes later in life. Thus, the timing of ascertainment of adiposity and its related factors is critical in understanding how it might fit into the pathogenesis of AD. We believe that the most plausible mechanism relating adiposity to AD is hyperinsulinemia, but it is unclear whether specific products of adipose tissue also have a role. Being overweight or obese is increasing in children and adults, thus understanding the association between adiposity and AD has important public health implications.

Entities:  

Mesh:

Year:  2007        PMID: 17430235      PMCID: PMC1890025          DOI: 10.2174/156720507780362100

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  77 in total

1.  The origins of Alzheimer disease: a is for amyloid.

Authors:  D J Selkoe
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

Review 2.  Cardiovascular risk factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

3.  Insulin resistance precedes weight loss in adults without diabetes : the Rancho Bernardo Study.

Authors:  N M Wedick; E J Mayer-Davis; D L Wingard; C L Addy; E Barrett-Connor
Journal:  Am J Epidemiol       Date:  2001-06-15       Impact factor: 4.897

4.  The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

Authors:  Trevor J Orchard; Marinella Temprosa; Ronald Goldberg; Steven Haffner; Robert Ratner; Santica Marcovina; Sarah Fowler
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

5.  The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.

Authors:  Andreas Festa; Ken Williams; Ralph D'Agostino; Lynne E Wagenknecht; Steven M Haffner
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

6.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

7.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

8.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

9.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

10.  Trends in waist circumference among U.S. adults.

Authors:  Earl S Ford; Ali H Mokdad; Wayne H Giles
Journal:  Obes Res       Date:  2003-10
View more
  20 in total

Review 1.  Obesity, leptin, and Alzheimer's disease.

Authors:  Edward B Lee
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

2.  Obesity/hyperleptinemic phenotype adversely affects hippocampal plasticity: effects of dietary restriction.

Authors:  Claudia A Grillo; Gerardo G Piroli; Ashlie N Evans; Victoria A Macht; Steven P Wilson; Karen A Scott; Randall R Sakai; David D Mott; Lawrence P Reagan
Journal:  Physiol Behav       Date:  2010-10-29

Review 3.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

4.  Change in body mass index before and after Alzheimer's disease onset.

Authors:  Yian Gu; Nikolaos Scarmeas; Stephanie Cosentino; Jason Brandt; Marilyn Albert; Deborah Blacker; Bruno Dubois; Yaakov Stern
Journal:  Curr Alzheimer Res       Date:  2014-05       Impact factor: 3.498

Review 5.  Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke.

Authors:  Adrià Arboix
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

6.  Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.

Authors:  Michael L Alosco; Jonathan Duskin; Lilah M Besser; Brett Martin; Christine E Chaisson; John Gunstad; Neil W Kowall; Ann C McKee; Robert A Stern; Yorghos Tripodis
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Effect of resveratrol and environmental enrichment on biomarkers of oxidative stress in young healthy mice.

Authors:  Mustapha Shehu Muhammad; Rabiu Abdussalam Magaji; Aliyu Mohammed; Ahmed-Sherif Isa; Mohammed Garba Magaji
Journal:  Metab Brain Dis       Date:  2016-08-15       Impact factor: 3.584

Review 8.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

9.  Self-reported vs measured body mass indices in migraineurs.

Authors:  Michael J Katsnelson; B Lee Peterlin; Andrea L Rosso; Guillermo M Alexander; Kirsten L Erwin
Journal:  Headache       Date:  2009-05       Impact factor: 5.887

Review 10.  A look inside the diabetic brain: Contributors to diabetes-induced brain aging.

Authors:  Shayna A Wrighten; Gerardo G Piroli; Claudia A Grillo; Lawrence P Reagan
Journal:  Biochim Biophys Acta       Date:  2008-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.